help button home button Endocrine Society Endocrinology
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

Endocrinology, doi:10.1210/en.2006-1064
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
148/3/1039    most recent
Author Manuscript (PDF)
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Copyright Permission
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Clerc, P.
Right arrow Articles by Dufresne, M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Clerc, P.
Right arrow Articles by Dufresne, M.
Endocrinology Vol. 148, No. 3 1039-1049
Copyright © 2007 by The Endocrine Society

Involvement of Cholecystokinin 2 Receptor in Food Intake Regulation: Hyperphagia and Increased Fat Deposition in Cholecystokinin 2 Receptor-Deficient Mice

Pascal Clerc1, Maria Gràcia Coll Constans1, Hubert Lulka, Stéphanie Broussaud, Charlotte Guigné, Stéphane Leung-Theung-Long, Christophe Perrin, Claude Knauf, Christian Carpéné, Luc Pénicaud, Catherine Seva, Rémy Burcelin, Philippe Valet, Daniel Fourmy and Marlène Dufresne

Institut National de la Santé et de la Recherche Médicale, Unit 531 (P.C., M.G.C.C., H.L., S.B., S.L.-T.-L., C.S., D.F., M.D.), Institut Fédératif de Recherche 31, Université de Toulouse 3, 31432 Toulouse, France; Animal Facility (H.L.), Institut Fédératif de Recherche 31, 31432 Toulouse, France; Institut National de la Santé et de la Recherche Médicale, Unit 586 (C.G., C.C., P.V.), Institut Fédératif de Recherche 31, 31432 Toulouse, France; and Centre National de la Recherche Scientifique (C.P., C.K., L.P., R.B.), Unité Mixte de Recherche 5018, Institut Fédératif de Recherche 31, Université de Toulouse 3, 31432 Toulouse, France

Address all correspondence and requests for reprints to: Marlène Dufresne, Institut National de la Santé et de la Recherche Médicale, Unit 531, Institut Fédératif de Recherche 31, Institut Louis Bugnard, BP 84225, 31432 Toulouse Cedex 4, France. E-mail: dufresne{at}toulouse.inserm.fr.

The role of cholecystokinin (CCK) as a satiety factor has been extensively documented. Although most work implies that CCK1 receptor mediates the control of food intake, a contributing role for CCK2 receptor (CCK2R) in the CCK-induced satiety cannot be totally excluded. The hypothesis that CCK2R invalidation disrupts regulatory pathways with impact on feeding behavior was examined in CCK2R–/– mice. CCK2R–/– mice developed obesity that was associated with hyperphagia. Obesity was related with increased fat deposition resulting from adipocyte hypertrophy. Expression of several adipokines was dysregulated consistently with obesity. Moreover, obesity was associated with disturbed glucose homeostasis as revealed by increased fasting glycemia and insulinemia, impaired glucose tolerance, and hepatic insulin resistance in CCK2R–/– mice. In vitro analysis of isolated adipocytes metabolism was consistent with increased storage but preserved insulin sensitivity. Suppression of feeding and concomitant increased expression of hypothalamic proopiomelanocortin after intracerebroventricular injection of gastrin into control mice demonstrates that hypothalamic CCK2 receptors mediate inhibition of food intake. Comparative analysis of hypothalamic mediator gene expression in fed knockout and control mice demonstrated overexpression of ghrelin receptors in CCK2R–/– mice, indicating up-regulation of orexigenic pathways. This effect was also observed after body weight normalization, indicating a causative role in the development of hyperphagia and obesity of CCK2R–/– mice. Our results give evidence that CCK2 receptor activity plays a contributing regulatory role in the control of food intake.




This article has been cited by other articles:


Home page
EndocrinologyHome page
T. Janssen, E. Meelkop, M. Lindemans, K. Verstraelen, S. J. Husson, L. Temmerman, R. J. Nachman, and L. Schoofs
Discovery of a Cholecystokinin-Gastrin-Like Signaling System in Nematodes
Endocrinology, June 1, 2008; 149(6): 2826 - 2839.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Regul. Integr. Comp. Physiol.Home page
C.-M. Lo, L. C. Samuelson, J. B. Chambers, A. King, J. Heiman, R. J. Jandacek, R. R. Sakai, S. C. Benoit, H. E. Raybould, S. C. Woods, et al.
Characterization of mice lacking the gene for cholecystokinin
Am J Physiol Regulatory Integrative Comp Physiol, March 1, 2008; 294(3): R803 - R810.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Endocrinology Endocrine Reviews J. Clin. End. & Metab.
Molecular Endocrinology Recent Prog. Horm. Res. All Endocrine Journals
Copyright © 2007 by The Endocrine Society